Metformin as Targeted Treatment in Fragile X Syndrome
Background Individuals with fragile X syndrome (FXS) have both behavioral and medical comorbidities and the latter include obesity in approximately 30% and the Prader‐Willi Phenotype (PWP) characterized by severe hyperphagia and morbid obesity in less than 10%. Metformin is a drug used in individual...
Saved in:
Main Authors: | , , , , , |
---|---|
格式: | text |
出版: |
Archīum Ateneo
2017
|
主題: | |
在線閱讀: | https://archium.ateneo.edu/asmph-pubs/23 https://onlinelibrary.wiley.com/doi/full/10.1111/cge.13039 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Ateneo De Manila University |